Toru Ogasawara

Dr. Toru Ogasawara

Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2006 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
HYHisayo Yamaoka
Hisayo Yamaoka
HAHirotaka Asato
Hirotaka Asato
TOToru Ogasawara
Toru Ogasawara
SNSatoru Nishizawa
Satoru Nishizawa
TTTsuguharu Takahashi
Tsuguharu Takahashi
KHKazuto Hoshi
Kazuto Hoshi

1 March 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TSTakashi Shimoaka
Takashi Shimoaka
TOToru Ogasawara
Toru Ogasawara
AYAkiko Yonamine
Akiko Yonamine
DCDaichi Chikazu
Daichi Chikazu
HKHirotaka Kawano
Hirotaka Kawano
HKHiroshi Kawaguchi
Hiroshi Kawaguchi
This study investigated the actions of fibroblast growth factor (FGF)-18, a novel member of the FGF family, on osteoblasts, chondrocytes, and osteoclasts and compared them with those of FGF-2 and FGF-10. FGF-18 stimulated the proliferation of cultured mouse primary osteoblasts, osteoblastic MC3T3-E1 cells, primary chondrocytes, and prechondrocytic ATDC5 cells, although it inhibited the differentiation and matrix synthesis of these cells. FGF-18 up-regulated the phosphorylation of extracellular signal-regulated kinase in both osteoblasts and chondrocytes and up-regulated the phosphorylation of p38 mitogen-activated protein kinase only in chondrocytes. FGF-18 mitogenic actions were blocked by a specific inhibitor of extracellular signal-regulated kinase in both osteoblasts and chondrocytes and by a specific inhibitor of p38 mitogen-activated protein kinase in chondrocytes. With regard to the action of FGF-18 on bone resorption, FGF-18 not only induced osteoclast formation through receptor activator of nuclear factor-κB ligand and cyclooxygenase-2 but also stimulated osteoclast function to form resorbed pits on a dentine slice in the mouse coculture system. All these effects of FGF-18 bore a close resemblance to those of FGF-2, whereas FGF-10 affects none of these cells. FGF-18 may therefore compensate for the action of FGF-2 on bone and cartilage.

1 October 2004 in Genes & Development
Verified
Journal Article
Open access
PDF file
HCHirotaka Chikuda
Hirotaka Chikuda
FKFumitaka Kugimiya
Fumitaka Kugimiya
KHKazuto Hoshi
Kazuto Hoshi
TIToshiyuki Ikeda
Toshiyuki Ikeda
TOToru Ogasawara
Toru Ogasawara
HKHiroshi Kawaguchi
Hiroshi Kawaguchi
The Komeda miniature rat Ishikawa (KMI) is a naturally occurring mutant caused by an autosomal recessive mutation mri, which exhibits longitudinal growth retardation. Here we identified the mri mutation as a deletion in the rat gene encoding cGMP-dependent protein kinase type II (cGKII). KMIs showed an expanded growth plate and impaired bone healing with abnormal accumulation of postmitotic but nonhypertrophic chondrocytes. Ex vivo culture of KMI chondrocytes reproduced the differentiation impairment, which was restored by introducing the adenovirus-mediated cGKII gene. The expression of Sox9, an inhibitory regulator of hypertrophic differentiation, persisted in the nuclei of postmitotic chondrocytes of the KMI growth plate. Transfection experiments in culture systems revealed that cGKII attenuated the Sox9 functions to induce the chondrogenic differentiation and to inhibit the hypertrophic differentiation of chondrocytes. This attenuation of Sox9 was due to the cGKII inhibition of nuclear entry of Sox9. The impaired differentiation of cultured KMI chondrocytes was restored by the silencing of Sox9 through RNA interference. Hence, the present study for the first time shed light on a novel role of cGKII as a molecular switch, coupling the cessation of proliferation and the start of hypertrophic differentiation of chondrocytes through attenuation of Sox9 function.

1 August 2004 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
TOToru Ogasawara
Toru Ogasawara
HKHiroshi Kawaguchi
Hiroshi Kawaguchi
SJShigeki Jinno
Shigeki Jinno
KHKazuto Hoshi
Kazuto Hoshi
KIKeiji Itaka
Keiji Itaka
HOHiroto Okayama
Hiroto Okayama
Because a temporal arrest in the G1 phase of the cell cycle is thought to be a prerequisite for cell differentiation, we investigated cell cycle factors that critically influence the differentiation of mouse osteoblastic MC3T3-E1 cells induced by bone morphogenetic protein 2 (BMP-2), a potent inducer of osteoblast differentiation. Of the G1 cell cycle factors examined, the expression of cyclin-dependent kinase 6 (Cdk6) was found to be strongly down-regulated by BMP-2/Smads signaling, mainly via transcriptional repression. The enforced expression of Cdk6 blocked BMP-2-induced osteoblast differentiation to various degrees, depending on the level of its overexpression. However, neither BMP-2 treatment nor Cdk6 overexpression significantly affected cell proliferation, suggesting that the inhibitory effect of Cdk6 on cell differentiation was exerted by a mechanism that is largely independent of its cell cycle regulation. These results indicate that Cdk6 is a critical regulator of BMP-2-induced osteoblast differentiation and that its Smads-mediated down-regulation is essential for efficient osteoblast differentiation.

1 August 2005 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
FYFumiko Yano
Fumiko Yano
FKFumitaka Kugimiya
Fumitaka Kugimiya
SOShinsuke Ohba
Shinsuke Ohba
TIToshiyuki Ikeda
Toshiyuki Ikeda
HCHirotaka Chikuda
Hirotaka Chikuda
UCUng-Il Chung
Ung-Il Chung

1 May 2008 in Developmental Cell
Verified
Journal Article
Closed access
SOShinsuke Ohba
Shinsuke Ohba
HKHiroshi Kawaguchi
Hiroshi Kawaguchi
FKFumitaka Kugimiya
Fumitaka Kugimiya
TOToru Ogasawara
Toru Ogasawara
NKNaohiro Kawamura
Naohiro Kawamura
UCUng-Il Chung
Ung-Il Chung